COMT-inhibition: An important option in treatment of Parkinson's disease

被引：0
|
作者：
Reichmann, H [1 ]
机构：
[1] Tech Univ Dresden, Neurol Klin & Poliklin, D-01307 Dresden, Germany
来源：
AKTUELLE NEUROLOGIE | 2005年 / 32卷
关键词：
D O I：
10.1055/s-2005-866979
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S297 / S298
页数：2
相关论文
共 50 条
  • [21] Opicapone (Ongentys): A New COMT Inhibitor for the Treatment of Parkinson's Disease
    St Onge, Erin
    Vanderhoof, Michelle
    Miller, Shannon
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (09) : 1159 - 1166
  • [22] The place of COMT inhibitors in the armamentarium of drugs for the treatment of Parkinson's disease
    Schapira, AHV
    Obeso, JA
    Olanow, CW
    [J]. NEUROLOGY, 2000, 55 (11) : S65 - S68
  • [23] COMT Inhibitors in the Management of Parkinson's Disease
    Fabbri, Margherita
    Ferreira, Joaquim J.
    Rascol, Olivier
    [J]. CNS DRUGS, 2022, 36 (03) : 261 - 282
  • [24] The effect of COMT inhibition with entacapone on cardiorespiratory responses to exercise in patients with Parkinson's disease
    Lyytinen, J
    Kaakkola, S
    Gordin, A
    Kultalahti, ER
    Teräväinen, H
    Sovijärvi, A
    [J]. PARKINSONISM & RELATED DISORDERS, 2002, 8 (05) : 349 - 355
  • [25] COMT Inhibitors in the Management of Parkinson’s Disease
    Margherita Fabbri
    Joaquim J. Ferreira
    Olivier Rascol
    [J]. CNS Drugs, 2022, 36 : 261 - 282
  • [26] A New (Old) Treatment Option for Depression in Parkinson's Disease
    Black, Kevin J.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (10): : 1015 - 1016
  • [27] Posteroventral pallidotomy: A treatment option for advanced Parkinson's disease
    Kishore, A
    [J]. NEUROLOGY INDIA, 1997, 45 (04) : 208 - 210
  • [28] Clinical benefit of MAO-B and COMT inhibition in Parkinson’s disease: practical considerations
    Martin Regensburger
    Chi Wang Ip
    Zacharias Kohl
    Christoph Schrader
    Peter P. Urban
    Jan Kassubek
    Wolfgang H. Jost
    [J]. Journal of Neural Transmission, 2023, 130 : 847 - 861
  • [29] Perspectives in the treatment of Parkinson's disease: COMT inhibitors open up new treatment strategies
    Rabasseda, X
    [J]. DRUGS OF TODAY, 1999, 35 (09) : 701 - 717
  • [30] Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations
    Regensburger, Martin
    Ip, Chi Wang
    Kohl, Zacharias
    Schrader, Christoph
    Urban, Peter P.
    Kassubek, Jan
    Jost, Wolfgang H.
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (06) : 847 - 861
12345